VEGFA and melanoma: Although VEGF-A-dependent angiogenesis is a characteristic feature of malignant melanoma [36], anti-VEGF-A therapy may have limited potential in patients with melanoma brain metastases due to a tendency of melanoma cells to grow by vascular co-option in the brain despite high expression of VEGF-A.